The FDA declared the semaglutide shortage resolved in February 2025, which technically limits when 503A pharmacies can compound semaglutide
Figure 2: Categorical weight loss of either 5%, 10%, or 15% in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
GLP-1 medications such as Ozempic tend to come in the form of an injection
insulin should be adjusted gradually with careful glucose monitoring
For a drinking-focused goal, that combination is hard to beat right now
Our providers screen for contraindications and health conditions, dose appropriately based on your goals and response, monitor for side effects or complications, and adjust protocols based on your progress and feedback